supp.fit

Policosanol: study protocols

8 study groups say how much Policosanol participants took a day. These are the doses the studies gave. They are not a recommendation.

Policosanol: what the research found →

Dose per serving from products

256 products in our catalogue print how much Policosanol a serving holds.

Most common: 5 mg to 10 mg, 64% of 256 products.

Dose per servingProducts
2.5 mg or less
3
2.5 mg to 5 mg
20
5 mg to 10 mg
165
10 mg to 25 mg
48
25 mg to 50 mg
12
over 50 mg
8

Dose per serving from research

8 study groups in 6 studies say how much Policosanol participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 mg to 25 mg, 38% of 8 study groups.

Daily doseStudy groups
2.5 mg to 5 mg
2
5 mg to 10 mg
1
10 mg to 25 mg
3
25 mg to 50 mg
2

Commonly used together

None of these 8 study groups took Policosanol with anything else.

8 study groups

Study
Efficacy and Safety of Policosanol (Sugarcane Wax Alcohols) 20 mg/Day in Cuban Prehypertensive Patients: A Randomized, Double-Blind, Multicentre Study
2025 · Policosanol · Women and men aged 20–60 with prehypertension and 0–2 cardiovascular risk factors
20 mg12 weeks100
Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study
2025 · Policosanol · Women and men aged 20–60 years with grade I hypertension and 0–2 cardiovascular risk factors
20 mg12 weeks100
Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study
2001 · policosanol 20 mg/day · Patients with type II hypercholesterolemia
20 mg24 weeks29
Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors
1999 · Policosanol group, next 12 weeks · Patients with type II hypercholesterolemia and additional coronary risk factors
10 mg12 weeks—
Concomitant use of policosanol and beta-blockers in older patients
2004 · policosanol · Older hypercholesterolemic patients taking beta-blockers; age range and sex not specified
5 mg3 years98
Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study
2001 · policosanol 40 mg/day · Patients with type II hypercholesterolemia
40 mg24 weeks30
Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors
1999 · Policosanol group, first 12 weeks · Patients with type II hypercholesterolemia and additional coronary risk factors
5 mg12 weeks—
Safety and efficacy of policosanol in patients with high on-treatment platelet reactivity after drug-eluting stent implantation: two-year follow-up results
2016 · group C · Patients with high on-treatment platelet reactivity after drug-eluting stent implantation; age and sex not reported
40 mg26 weeks150